J8560 HCPCS code: Etoposide; oral, 50 mg
J8560 is the HCPCS Level II code for etoposide; oral, 50 mg. In 2024 Medicare paid an average of $59.64 per service for J8560 across 15,825 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 6 per day on outpatient hospital claims. Medicare volume fell 19% from 2022 to 2024 (19,631 to 15,825 services). In 2024, 155 suppliers billed Medicare for J8560 (purchases), serving 339 beneficiaries; California, New York, Florida accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1995-01-01 |
Who bills J8560 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 155 |
| Referring clinicians | 343 |
| Medicare beneficiaries | 339 |
| States with claims | 27 |
| Share of services in top 3 states (California, New York, Florida) | 32% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 191 | 392 |
| 2023 | 201 | 400 |
| 2024 | 155 | 339 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J8560, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 19,631 | 392 | $75.62 | $59.27 |
| 2023 | 22,103 | 400 | $76.61 | $59.67 |
| 2024 | 15,825 | 339 | $76.27 | $59.64 |
States with the most J8560 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 1,964 | $59.68 |
| New York | 1,727 | $59.89 |
| Florida | 1,092 | $59.89 |
| Wisconsin | 1,025 | $58.38 |
| Iowa | 873 | $59.79 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 6 | Prescribing Information |
What changed for J8560
- 1995-01-01: J8560 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J8560?
J8560 is the HCPCS Level II code for etoposide; oral, 50 mg. Short descriptor: "Etoposide oral 50 mg".
How much does Medicare pay for J8560?
In 2024, the average Medicare payment was $59.64 per service (average allowed $76.27).
Does Medicare cover J8560?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J8560 can be billed per day?
6 on outpatient hospital claims (NCCI medically unlikely edits).
Related J85 codes
- J8501 — Aprepitant, oral, 5 mg
- J8502 — Injection, aprepitant (aponvie), 1 mg
- J8510 — Busulfan; oral, 2 mg
- J8515 — Cabergoline, oral, 0.25 mg
- J8520 — Capecitabine, oral, 150 mg
- J8521 — Capecitabine, oral, 500 mg
- J8522 — Capecitabine, oral, 50 mg
- J8530 — Cyclophosphamide; oral, 25 mg
- J8540 — Dexamethasone, oral, 0.25 mg
- J8541 — Dexamethasone (hemady), oral, 0.25 mg
- J8562 — Fludarabine phosphate, oral, 10 mg
- J8565 — Gefitinib, oral, 250 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J8560
- Watch J8560 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J8560
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.